Table 3.

Skin fold thickness.

SFT	CG	IG	P
Biceps (mm)
24–29 6/7 weeks	10.4 ± 1.1; 9.89–10.92, (20)	10.2 ± 0.6; 9.98–10.42, (30)	0.4
<27 weeks	11.5 ± 1.8; 8.6–14.4, (6)	10.2 ± 0.3, 9.8–10.5, (14)	0.3
Triceps (mm)
24–29 6/7 weeks	10.9 ± 1.0; 10.43–11.37, (20)	10.5 ± 0.6; 10.28–10.72, (30)	0.08
<27 weeks	12 ± 1.4; 9.7–14.4 (6)	10.6 ± 0.56; 10.3–11.1, (14)	0.1
Suprascapular (mm)
24–29 6/7 weeks	10.9 ± 0.9; 10.48–11.32, (20)	10.7 ± 0.7; 10.44–10.96, (30)	0.38
<27 weeks	11.6 ± 1.62; 9–14.1, (6)	10.6 ± 0.8; 10.1–11, (14)	0.3
Suprailiac (mm)
24–29 6/7 weeks	10.8 ± 0.9; 10.38–11.22, (20)	10.5 ± 0.5; 10.31–10.69, (30)	0.14
<27 weeks	11.7 ± 1.66;9–14.3, (6)	10.5 ± 0.53; 10.2–10.8, (14)	0.25
Total SFT (mm)
24–29 6/7 weeks	43.1 ± 3.7; 41.3–44.9, (20)	41.8 ± 1.9; 41.1–42.6, (30)	0.34
<27 weeks	46.8 ± 6.4; 36.6–56.9, (6)	41.9 ± 2.2; 40.7–43.1, (14)	0.02*

SFT, skin fold thickness; *Interventional compared to control group by unpaired T-test Welch corrected; all values are depicted as Mean ± SD; 95%CI, (N).